Analysis of the impact of TOR1B expression on DRFS in Basal-like and Luminal A breast cancer patients from the GSE25066 dataset showed that high TOR1B expression was associated with decreased DRFS in Basal-like breast cancer (P < 0.05) but had no significant effect on Luminal A DRFS (P > 0.05) (Fig. 3D, Supplementary Material 7). Here, TOR1B is linked to breast carcinoma.